Abnormal repetitive behaviors (stereotypies, self-injury, compulsions) are foremost among the varieties of aberrant behavior exhibited by individuals with mental retardation. Despite this, little is known about their pathobiology and efficacious somatic treatments are largely unconfirmed by controlled trials. For example, few controlled studies have examined the efficacy of pharmacological treatment of abnormal repetitive behavior in individuals with mental retardation. There is evidence, however, to hypothesize the efficacy of both 5-HT uptake inhibitors and atypical antipsychotics. Currently, there is little information to guide the clinician in deciding which drug class may be more effective for which categories of abnormal repetitive behaviors and for which individuals. Moreover, little work has attempted to identify variables that may predict differential treatment response. Thus, the focus of this proposal is to assess the relative efficacy of a selective serotonin reuptake inhibitor (SSRI) and an atypical antipsychotic across multiple categories of abnormal repetitive behaviors. In addition, we will build upon our previous work to establish sets of measures that (a) will provide novel information about repetitive behavior disorders, (b) will predict drug response, and (c) that will serve as outcome measures of drug efficacy.
The specific aims will include: 1) identifying the temporal structure and environmental dependence of repetitive and non-repetitive behavior disorders; 2) identifying physiological (motor, autonomic) variables that discriminate subjects with and without discrete categories of abnormal repetitive behaviors; 3) evaluating the differential efficacy of an atypical antipsychotic and a selective serotonin reuptake inhibitor (SSRI) in treating abnormal repetitive behaviors in individuals with mental retardation; 4) evaluating the utility of temporal, environmental and physiological variables as both predictors of drug response and outcomes of pharmacotherapy.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD030615-10
Application #
6773237
Study Section
Biobehavioral and Behavioral Processes 3 (BBBP)
Program Officer
Oster-Granite, Mary Lou
Project Start
1992-09-23
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
10
Fiscal Year
2004
Total Cost
$163,688
Indirect Cost
Name
University of Florida
Department
Psychiatry
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Woodard, Cooper; Groden, June; Goodwin, Matthew et al. (2007) A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism. Autism 11:29-41
Lewis, Mark H (2004) Environmental complexity and central nervous system development and function. Ment Retard Dev Disabil Res Rev 10:91-5
Bodfish, J W; Parker, D E; Lewis, M H et al. (2001) Stereotypy and motor control: differences in the postural stability dynamics of persons with stereotyped and dyskinetic movement disorders. Am J Ment Retard 106:123-34
Bodfish, J W; Symons, F J; Parker, D E et al. (2000) Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord 30:237-43
Rosenquist, P B; Bodfish, J W; Thompson, R (1997) Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol. Am J Ment Retard 101:497-504
Bodfish, J W; Newell, K M; Sprague, R L et al. (1997) Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS). Am J Ment Retard 101:413-23
Lewis, M H; Bodfish, J W; Powell, S B et al. (1996) Plasma HVA in adults with mental retardation and stereotyped behavior: biochemical evidence for a dopamine deficiency model. Am J Ment Retard 100:413-8
Bodfish, J W; Newell, K M; Sprague, R L et al. (1996) Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypy. Am J Ment Retard 101:118-29
Lewis, M H; Bodfish, J W; Powell, S B et al. (1996) Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo. Am J Ment Retard 100:654-65
Powell, S B; Bodfish, J W; Parker, D et al. (1996) Self-restraint and self-injury: occurrence and motivational significance. Am J Ment Retard 101:41-8

Showing the most recent 10 out of 15 publications